SEC14L2, SEC14 like lipid binding 2, 23541

N. diseases: 198; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.030 Biomarker group BEFREE In our previous studies in the rat JDCaP prostate cancer model, TAK-448 showed more rapid and profound reductions in plasma testosterone (T) and prostate-specific antigen (PSA, a biomarker of prostate tumor growth) levels than the gonadotropin releasing hormone (GnRH) analog leuprolide (TAP-144); however, its effects on tumor volume and subsequent tumor recurrence have not been elucidated fully. 29580912 2018
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.030 AlteredExpression group LHGDN Reduced expression of alpha-tocopherol-associated protein is associated with tumor cell proliferation and the increased risk of prostate cancer recurrence. 17334589 2007
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.030 Biomarker group LHGDN Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. 16267002 2005